Literature DB >> 10873028

Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair.

K W Liechty1, H B Kim, N S Adzick, T M Crombleholme.   

Abstract

BACKGROUND: Fetal dermal wound healing is characterized by minimal inflammation, restoration of normal dermal architecture, and scarless repair. The authors have shown that proinflammatory cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8) are diminished during fetal wound repair. Interleukin-10 (IL-10) is an antiinflammatory cytokine that decreases production of IL-6 and IL-8. The authors hypothesized that diminished IL-6 and IL-8 and minimal inflammation may be caused by IL-10.
METHODS: To test this hypothesis, the authors developed a new syngeneic murine model of fetal wound repair in which 15-day-gestation skin from either normal C57BL/6 or transgenic C57BL/6 IL-10 knockout mice was grafted to the back of the same strain adult mice. The grafts were incisionally wounded after 5 days, harvested at 1 week, and analyzed for inflammatory response and scar formation.
RESULTS: Wounds in normal fetal skin grafts showed minimal inflammation and normal dermal reticular collagen pattern at the site of the wound, consistent with scarless repair. In contrast, wounds in IL-10 knockout fetal skin grafts showed significant inflammation and scar formation.
CONCLUSIONS: Fetal skin grafts on adult syngeneic mice heal without inflammation or scar formation. The absence of IL-10 in fetal skin results in scar formation. Intrinsic lack of IL-10 may result in continued amplification of the inflammatory cytokine cascade, continued stimulation of fibroblasts, and abnormal collagen deposition. IL-10 is necessary for scarless wound repair to occur.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873028     DOI: 10.1053/jpsu.2000.6868

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  72 in total

1.  Regenerative healing following foetal myocardial infarction.

Authors:  Benjamin J Herdrich; Enrico Danzer; Marcus G Davey; Myron Allukian; Virginia Englefield; Joseph H Gorman; Robert C Gorman; Kenneth W Liechty
Journal:  Eur J Cardiothorac Surg       Date:  2010-05-10       Impact factor: 4.191

Review 2.  [Fetal wound healing: current status and new perspectives].

Authors:  E A Huhn; C Jannowitz; H Boos; M A Papadopulos; H F Zeilhofer; J Henke; D Müller; L Kovacs; E Biemer; N A Papadopulos
Journal:  Chirurg       Date:  2004-05       Impact factor: 0.955

3.  Innovative therapies in the treatment of keloids and hypertrophic scars.

Authors:  Martha H Viera; Sadegh Amini; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-05

4.  Accelerated wound closure in mice deficient for interleukin-10.

Authors:  Sabine A Eming; Sabine Werner; Philippe Bugnon; Claudia Wickenhauser; Lisa Siewe; Olaf Utermöhlen; Jeffrey M Davidson; Thomas Krieg; Axel Roers
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 5.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

Authors:  Austin Nuschke
Journal:  Organogenesis       Date:  2013-12-10       Impact factor: 2.500

Review 6.  Update on Keloid Management: Clinical and Basic Science Advances.

Authors:  Martha H Viera; Alejandra C Vivas; Brian Berman
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-10       Impact factor: 4.730

7.  Fibromodulin Is Essential for Fetal-Type Scarless Cutaneous Wound Healing.

Authors:  Zhong Zheng; Xinli Zhang; Catherine Dang; Steven Beanes; Grace X Chang; Yao Chen; Chen-Shuang Li; Kevin S Lee; Kang Ting; Chia Soo
Journal:  Am J Pathol       Date:  2016-09-22       Impact factor: 4.307

8.  The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing.

Authors:  Traci A Wilgus; Valerie K Bergdall; Kathleen L Tober; Kara J Hill; Srabani Mitra; Nicholas A Flavahan; Tatiana M Oberyszyn
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 9.  Naturally derived biomaterials for addressing inflammation in tissue regeneration.

Authors:  Rebecca A Hortensius; Brendan Ac Harley
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

10.  Prostaglandin E2 is activated by airway injury and regulates fibroblast cytoskeletal dynamics.

Authors:  Vlad C Sandulache; Tripti Singh; Ha Sheng Li-Korotky; Chia Y Lo; Todd D Otteson; Mark Barsic; Joseph E Dohar; Patricia A Hebda
Journal:  Laryngoscope       Date:  2009-07       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.